Physician profile
In Sok Yi
NPI 1346288099
$231,828.73
in general payments reported to CMS, 2019-2025
11 companies · $52.00 in 2025
The $52.00 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $57K · 2021: $62K · 2022: $49K · 2023: $58.80 · 2025: $52.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $110.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrosurface Incorporated | $118,175.53 | 2019-2020 | |
| Anika Therapeutics, INC. | $103,142.06 | 2021-2022 | |
| Microaire Surgical Instruments LLC | $4,721.69 | 2019-2022 | |
| Gemini Mountain Medical, LLC | $4,219.64 | 2020-2022 | |
| Exsomed Corporation | $987.50 | 2021-2022 | |
| Stryker Corporation | $294.02 | 2021-2022 | |
| Checkpoint Surgical, INC | $148.65 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $67.97 | 2019-2025 | Exparel |
| Avanos Medical | $43.98 | 2023 | On-Q* Pump and Accessories |
| Acumed LLC | $14.82 | 2023 | Acumed |
| Integra Lifesciences Corporation | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw In Yi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.